Emcure Pharma IPO Subscription
The Emcure Pharma IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
As per the latest subscription update, the Emcure Pharma IPO has received bids for 92,99,97,390 shares against 1,37,03,538 shares offered, resulting in an overall subscription of 67.87x. the NII category is subscribed 48.32x, Retail Investors 7.21x, Employees 8.81x, and QIBs 195.83x. Within the NII category, BNII is subscribed 53.79x, while SNII is subscribed 37.39x.
- Retail
- 7.21x
- NII
- 48.32x
- QIB
- 195.83x
- Total
- 67.87x
Current GMP
₹0 (0.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Emcure Pharma IPO Subscription Details ( Sat, 17 Aug 24 05:27 AM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 3,762,896 | 736,891,932 | 195.83x |
| Non-Institutional | 2,949,523 | 142,526,748 | 48.32x |
| Retail Investors | 6,882,219 | 49,618,982 | 7.21x |
| Employees | 108,900 | 959,728 | 8.81x |
| BNII (>₹10L) | 1,966,349 | 105,770,490 | 53.79x |
| SNII (₹2L–₹10L) | 983,174 | 36,756,258 | 37.39x |
| Total | 13,703,538 | 929,997,390 | 67.87x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 0 | - |
| Retail Investors | - | 0 | - |
| Employees | - | 0 | - |
| BNII (>₹10L) | - | 0 | - |
| SNII (₹2L–₹10L) | - | 0 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Emcure Pharma IPO Live Subscription Status?
You can check the Emcure Pharma IPO live subscription status on the IPO Master App or the official websites of the BSE,NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Emcure Pharma IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Emcure Pharma IPO was subscribed 7.21 times as of Sat, Aug 17, 2024 10:57 AM. The public issue closed on Fri, Jul 5, 2024 for bidding.
How to subscribe Emcure Pharma IPO?
Investors can apply for the Emcure Pharma IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Emcure Pharma IPO subscribed?
The Emcure Pharma IPO was subscribed 67.87x times at the close of bidding period on Fri, Jul 5, 2024.
How to check Emcure Pharma IPO allotment?
The Emcure Pharma IPO allotment was finalized on Mon, Jul 8, 2024. You can check the Emcure Pharma IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Emcure Pharma IPO Be Listed?
The Emcure Pharma IPO was listed on Wed, Jul 10, 2024, on the BSE,NSE.
What is the Emcure Pharma IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Emcure Pharma IPO was subscribed 195.83 times as of Sat, Aug 17, 2024 10:57 AM.